CD8A and neoplasm: In melanoma patients, CD8 T cell epitopes from NY-ESO-1 [2], MAGE [2], and BRAFV600E [77], have been reported, and may represent natural tumor-specific antigens that can be targeted for protective anti-tumor immunity without vitiligo.